1-4 of 4
Robert S Makar, MD PhD
Close
Sort by
Journal Articles

Utilization and Cost Effectiveness of a Risk Stratified Diagnostic Approach to Patients with Suspected Thrombotic Thrombocytopenic Purpura

Vivek Upadhyay, MD, Benjamin Geisler, Lova Sun, MD, Robert S Makar, MD PhD, Pavan Bendapudi, MD
Journal: Blood
Blood (2016) 128 (22): 1456.
https://doi.org/10.1182/blood.V128.22.1456.1456
Published: 2016
Journal Articles

Therapeutic Plasma Exchange for the Treatment of Thrombotic Microangiopathy without Severe ADAMTS13 Deficiency: A Propensity Score-Matched Study

Ang Li, MD, Robert S Makar, MD PhD, Shelley Hurwitz, PhD, Lynne Uhl, MD, Richard M. Kaufman, MD, Christopher P. Stowell, MD PhD, Walter Dzik, MD, Pavan Bendapudi, MD
Journal: Blood
Blood (2015) 126 (23): 3471.
https://doi.org/10.1182/blood.V126.23.3471.3471
Published: 2015
Journal Articles

Derivation and Prospective Validation of a Predictive Score for the Rapid Diagnosis of Thrombotic Thrombocytopenic Purpura: The Plasmic Score

Pavan K Bendapudi, MD, Ang Li, MD, Ayad Hamdan, MD, Ashley Michelle Fry, MD, Lynne Uhl, MD, Marisa Marques, MD, Richard Kaufman, MD, Christopher P. Stowell, MD PhD, Walter Sunny Dzik, MD, Robert S Makar, MD PhD
Journal: Blood
Blood (2014) 124 (21): 231.
https://doi.org/10.1182/blood.V124.21.231.231
Published: 2014
Journal Articles

Moderate Deficiency of ADAMTS13 in Thrombotic Microangiopathy Is Associated with Poor Survival Regardless of Plasma Exchange

Ang Li, MD, Pavan K Bendapudi, MD, Ayad Hamdan, MD, Robert S Makar, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4193.
https://doi.org/10.1182/blood.V124.21.4193.4193
Published: 2014